In contrast to the MCF10A mammary epithelial cells, ERα+ MCF7 breast cancer cells demonstrate an increase in activating histone marks H3K4ac, H3K4me3 and H3K27ac upon treatment with either steroid compound (E2 or EC10). The gene discussed is ESR1; the disease is breast carcinoma.